<DOC>
	<DOCNO>NCT02865447</DOCNO>
	<brief_summary>Sponsor conduct post-market study evaluate clinical outcome femoral bone mineral density ( BMD ) change associate PROFEMURÂ® PRESERVE hip stem use indicate primary total hip arthroplasty patient osteoarthritis hip joint .</brief_summary>
	<brief_title>Evaluation Bone Mineral Density Changes After Total Hip Replacement : A Two-Year Clinical DXA Analysis</brief_title>
	<detailed_description />
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>To include study , subject must meet following criterion : Subject minimum age 21 year , maximum age 80 Subject candidate primary THA osteoarthritis hip Subject able undergo primary elective THA procedure Subject willing able complete require study visit assessment Subject willing sign Institutional Review Board/Ethics Committee ( IRB/EC ) approve Informed Consent document . Subjects exclude meet follow criterion : Overt infection ; Distant focus infection ( may cause hematogenous spread implant site ) ; Rapid disease progression manifest joint destruction bone absorption apparent roentgenogram ; Skeletally immature ( less 21 year age time surgery ) ; Inadequate neuromuscular status ( e.g. , prior paralysis , fusion , and/or inadequate abductor strength ) , poor bone stock , poor skin coverage around joint would make procedure unjustifiable ; Neuropathic joint ; Known Hepatitis HIV infection ; Neurological musculoskeletal disease may adversely affect gait weightbearing Subjects know osteoporosis affected hip Subjects prior arthroplasty affected hip Subjects clinically obese ( &gt; 40 body mass index [ BMI ] ) Subjects femoral dysplasia affect hip Subjects trochanteric osteotomy affect hip Subject inflammatory arthritis affect hip Subjects currently take , take within 12 month enrollment , bisphosphonates , parathyroid hormone ( PTH ) , fluoride therapy strontium ranelate patient take chronic medication investigator 's opinion know affect BMD substantial way Subjects severe medical condition ( ) view investigator prohibit participation study Subjects currently enrol another clinical study could affect endpoint protocol Subjects know substance abuse issue Subjects incarcerate pending incarceration</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>dual energy x-ray absorptiometry</keyword>
	<keyword>DEXA</keyword>
	<keyword>DXA</keyword>
	<keyword>total hip arthroplasty</keyword>
	<keyword>PROFEMUR</keyword>
	<keyword>PRESERVE</keyword>
	<keyword>bone mineral density</keyword>
	<keyword>BMD</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>THA</keyword>
	<keyword>musculoskeletal disease</keyword>
</DOC>